Hypoxia-inducible factor 1 and cardiovascular disease

Annual Review of Physiology

Volumn 76, Issue , 2014, Pages 39-56

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Myocardial ischemia; Preconditioning; Pressure overload; Vascular remodeling

Indexed keywords

AGING; ANIMALS; CARDIOVASCULAR DISEASES; HEART FAILURE; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION;

EID: 84886412451     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021113-170322     Document Type: Article

References (119)

1. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230-377
2. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92:5510-144
3. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, et al. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1?. Genes Dev. 12:149-622
4. Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, et al. 2003. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1?. Cardiovasc. Res. 60:569-799
5. Yoon D, Pastore YD, Divoky V, Liu E,Mlodnicka AE, et al. 2006. Hypoxia-inducible factor 1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J. Biol. Chem. 281:25703-111
6. Lage K, Greenway SC, Rosenfeld JA, Wakimoto H, Gorham JM, et al. 2012. Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc. Natl. Acad. Sci. USA 109:14035-400
7. Wiener CM, Booth G, Semenza GL. 1996. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225:485-888
8. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR. 1999. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11:4159-700
9. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, et al. 1998. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178:527-344
10. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, et al. 2000. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:626-333
11. J urgensen JS, Rosenberger C, Wiesener MS,WarneckeC,Horstrup JH, et al. 2004. Persistent induction of HIF-1and -2in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J. 18:1415-177
12. Rosenberger C, Mandriota S, J urgensen JS, Wiesener MS, Horstrup JH, et al. 2002. Expression of hypoxia-inducible factor 1and 2in hypoxic and ischemic rat kidneys. J. Am. Soc. Nephrol. 13:1721-322
13. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, et al. 1998. Temporal, spatial, and oxygenregulated expression of hypoxia-inducible factor 1 in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 275:L818-266
14. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, et al. 2007. Effects of aging and hypoxiainducible factor 1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 101:1310-188
15. Kaelin WG Jr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30:393-4022
16. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271:32529-377
17. Semenza GL, Wang GL. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447-544
18. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, et al. 2009. Integrative analysis of HIF binding and transactivation reveals its role inmaintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. USA 106:4260-655
19. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, et al. 2009. Genome-wide association of hypoxia-inducible factor (HIF)-1 and HIF-2 DNA binding with expression profiling of hypoxiainducible transcripts. J. Biol. Chem. 284:16767-755
20. Schodel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, Mole DR. 2011. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117:e207-177
21. Kelly BD,Hackett SF, Hirota K, Oshima Y,Cai Z, et al. 2003. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93:1074-811
22. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. Am. Heart Assoc. Stat.Comm./Stroke Stat. Subcomm. 2012. Heart disease and stroke statistics -2012 update: a report from the American Heart Association. Circulation 125:e2-2200
23. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. 2003. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210-144
24. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, et al. 1991. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 83:739-466
25. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, et al. 1992. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N. Engl. J. Med. 327:1825-311
26. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, et al. 1999. Age-dependent impairment of angiogenesis. Circulation 99:111-200
27. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV. 2005. Constitutively active HIF-1 improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc. Res. 68:144-544
28. Rey S, Lee K, Wang CJ, Gupta K, Chen S, et al. 2009. Synergistic effect of HIF-1gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc. Natl. Acad. Sci. USA 106:20399-4044
29. Rey S, Luo W, Shimoda LA, Semenza GL. 2011. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue. Blood 117:4988-988
30. Hinkel R, Lebherz C, Fydanaki M, Wuchrer A, El-Aouni C, et al. 2013. Angiogenetic potential of Ad2/Hif-1/VP16 after regional application in a preclinical pig model of chronic ischemia. Curr. Vasc. Pharmacol. 11:29-377
31. Kilian EG, Sadoni S, Vicol C, Kelly R, van Hulst K, et al. 2010. Myocardial transfection of hypoxiainducible factor 1via an adenoviral vector during coronary artery bypass grafting. A multicenter phase I and safety study. Circ. J. 74:916-244
32. Resar JR, Roguin A, Voner J, Nasir K, Hennebry TA, et al. 2005. Hypoxia-inducible factor 1 polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 128:787-911
33. Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, et al. 2007. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am.Heart J. 154:1035-422
34. Duran J, Gotzens V, Carballo J, Martin E, Petit M, et al. 2012. The HIF1A C85T polymorphism influences the number of branches of the human coronary tree. Cardiology 121:156-599
35. Nallamothu BK, Bradley EH, Krumholz HM. 2007. Time to treatment in primary percutaneous coronary intervention. N. Engl. J. Med. 357:1631-388
36. Braunwald E, Kloner RA. 1985. Myocardial reperfusion: a double-edged sword? J. Clin. Investig. 76:1713-199
37. Murry CE, Jennings RB, Reimer KA. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-366
38. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, et al. 1993. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ. Res. 72:1293-999
39. Marber MS, Latchman DS, Walker JM, Yellon DM. 1993. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-722
40. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, et al. 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350-566
41. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, et al. 2008. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1?. Cardiovasc. Res. 77:463-700
42. Sarkar K, Cai Z, Gupta R, Parajuli N, Fox-Talbot K, et al. 2012. Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc. Natl. Acad. Sci. USA 109:10504-99
43. Armstrong S, Ganote CE. 1994. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc. Res. 28:1049-566
44. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. 2007. Cardioprotection by ecto-5 -nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581-900
45. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, et al. 2007. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116:1784-944
46. Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK. 2008. Hypoxia-inducible factor 1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118:166-755
47. Koszalka P, Ozuyaman B, Huo Y, Zernecke A, Flogel U, et al. 2004. Targeted disruption of cd73/ecto-5 -nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95:814-211
48. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL. 1997. Transactivation and inhibitory domains of hypoxia-inducible factor 1. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272:19253-600
49. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, et al. 2003. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-855
50. Xi L, Taher M, Yin C, Salloum F, Kukreja RC. 2004. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1and AP-1 and iNOS signaling. Am. J. Physiol. Heart Circ. Physiol. 287:H2369-755
51. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, et al. 2005. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am. J. Physiol. Heart Circ. Physiol. 289:H542-488
52. Jung F, Palmer LA, Zhou N, Johns RA. 2000. Hypoxic regulation of inducible nitric oxide synthase via hypoxia-inducible factor 1 in cardiac myocytes. Circ. Res. 86:319-255
53. Semenza GL. 2011. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 76:347-533
54. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, et al. 2007. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111-222
55. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. CellMetab. 3:177-855
56. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3:187-977
57. Lu CW, Lin SC, Chen KF, Lai YY, Tsai SJ. 2008. Induction of pyruvate dehydrogenase kinase 3 by hypoxia-inducible factor 1 promotes metabolic switch and drug resistance. J. Biol. Chem. 283:28106-144
58. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, et al. 2009. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10:273-844
59. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, et al. 2010. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5:e103455
60. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, et al. 2008. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283:10892-9033
61. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, et al. 2009. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29:2570-811
62. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. 2010. Heart disease and stroke statistics -2010 update: a report from the American Heart Association. Circulation 121:e46-2155
63. Levy D, Garrison RJ, Savage DD, Dannel WB, Castelli WP. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322:1561-666
64. Frohlich ED, Apstein C, Chobanian AV, Devereaux RB, Dustan HP, et al. 1992. The heart in hypertension. N. Engl. J. Med. 327:998-10088
65. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, et al. 2007. p53-induced inhibition of HIF-1 causes cardiac dysfunction during pressure overload. Nature 446:444-88
66. Wei H, Bedja D, Koitabashi N, Xing D, Chen J, et al. 2012. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-βsignaling. Proc. Natl. Acad. Sci. USA 109:E841-500
67. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, et al. 2011. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J. Clin. Investig. 121:2301-122
68. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, et al. 2008. Digoxin and other cardiac glycosides inhibit HIF-1synthesis and block tumor growth. Proc. Natl. Acad. Sci. USA 105:19579-866
69. Eade E, Cooper R, Mitchell AR. 2013. Digoxin -time to take the gloves off? Int. J. Cardiol. 164:365-677
70. Lehman JJ, Kelly DP. 2002. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail. Rev. 7:175-855
71. Taegtmeyer H, Golfman L, Sharma S, van Arsdall M. 2004. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann. NY Acad. Sci. 1015:202-133
72. Krishnan J, Suter M, Windak R, Krebs T, Felley A, et al. 2009. Activation of a HIF-1-PPAR axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab. 9:512-244
73. Silter M, Kogler H, Zieseniss A,Wilting J, Schafer K, et al. 2010. Impaired Ca2+ handling inHIF-1+/ mice as a consequence of pressure overload. Pflug. Arch. 459:569-777
74. Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. 2011. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145:732-444
75. Schito L, Rey S, Tafani M, Zhang H, Wong CC, et al. 2012. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc. Natl. Acad. Sci. USA 109:E2707-166
76. Chaturvedi P, Gilkes DM, Wong CC, Kshitiz, Luo W, et al. 2013. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J. Clin. Investig. 123:189-2055
77. Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, et al. 2012. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31:1757-700
78. Mukhopadhyay CK, Mazumder B, Fox PL. 2000. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275:21048-544
79. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97:9082-877
80. Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, et al. 2007. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int. J. Oncol. 30:112-222
81. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, et al. 2007. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11:407-200
82. Cormier-Regard S, Nguyen SV, Claycomb WC. 1998. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273:17787-922
83. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, et al. 2005. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105:659-699
84. Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, et al. 2009. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability.Am. J. Physiol. Lung Cell. Mol. Physiol. 297:L837-455
85. Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM, et al. 2009. Adenosine A2A receptor is a unique angiogenic target of HIF-2in pulmonary endothelial cells. Proc. Natl. Acad. Sci. USA 106:10684-899
86. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. 2006. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20:2242-500
87. Eckhart AD, Yang N, Xin X, Faber JE. 1997. Characterization of the 1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 94:9487-922
88. Simon MP, Tournaire R, Pouyssegur J. 2008. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J. Cell. Physiol. 217:809-188
89. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, et al. 2008. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ. Res. 103:432-400
90. Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, et al. 2007. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J. Neuroinflamm. 4:122
91. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, et al. 2004. Hypoxic induction of CTGF is directly mediated by HIF-1. Am. J. Physiol. Ren. Physiol. 287:F1223-322
92. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, et al. 2003. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198:1391-4022
93. Hu J, Discher DJ, Bishopric NH, Webster KA. 1998. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245:894-999
94. Camenisch G, Stroka DM, Gassmann W, Wenger RH. 2001. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Pflug. Arch. 443:240-499
95. Patel N, Gonsalves CS, Malik P, Kalra VK. 2008. Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1?. Blood 112:856-655
96. Vihanto MM, Plock J, Emi D, Frey BM, Frey FJ, et al. 2005. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J. 19:1689-911
97. Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, et al. 2008. Hypoxia-inducible transcription factor 2in endothelial cells regulates tumor neovascularization through activation of ephrin A1. J. Biol. Chem. 283:18926-366
98. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C. 2002. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-βpathways. J. Biol. Chem. 277:43799-8088
99. Gerber HP, Condorelli F, Park J, Ferrara N. 1997. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. J. Biol. Chem. 272:23659-677
100. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, et al. 2006. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J. Biol. Chem. 281:15554-633
101. Han ZB, Ren H, Zhao H, Chi Y, Chen K, et al. 2008. Hypoxia-inducible factor (HIF)-1 directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 29:1853-611
102. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, et al. 2002. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J. Biol. Chem. 277:42953-577
103. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. 2004. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem. 279:37124-322
104. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, et al. 2001. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-844
105. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858-644
106. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-133
107. Ryan HE, Lo J, Johnson RS. 1998. HIF-1 is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005-155
108. Jean JC, Rich CB, Joyce-Brady M. 2006. Hypoxia results in an HIF-1-dependent induction of brainspecific aldolase C in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L950-566
109. Sowter HM, Ratcliffe PJ,Watson P, Greenberg AH, Harris AL. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:6669-733
110. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. 1999. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim. Biophys. Acta 1447:208-188
111. Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, et al. 2002. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br. J. Cancer 86:1914-199
112. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. 1994. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3 enhancer. Proc. Natl. Acad. Sci. USA 91:6496-5000
113. Minchenko O, Opentanova I, Caro J. 2003. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett. 554:264-700
114. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, et al. 1998. Role of HIF-1 in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-900
115. Wood SM, Wiesener MS, Yeates KM, Okada N, Pugh CW, et al. 1998. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1-subunit (HIF-1). Characterization of HIF-1-dependent and -independent hypoxia-inducible gene expression. J. Biol. Chem. 273:8360-688
116. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL. 2006. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L941-499
117. Ullah MS, Davies AJ, Halestrap AP. 2006. The plasma membrane lactate transporter MCT4, but not MCT1, is upregulated by hypoxia through aHIF-1-dependent mechanism. J. Biol. Chem. 281:9030-377
118. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, et al. 2010. Imatinib resistance associated with BCRABL upregulation is dependent on HIF-1-induced metabolic reprograming. Oncogene 29:2962-722
119. Gess B, Hofbauer KH, Deutzmann R, Kurtz A. 2004. Hypoxia upregulates triosephosphate isomerase expression via a HIF-dependent pathway. Pflug. Arch. 448:175-800